Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.71 USD | +1.87% |
|
+7.74% | +124.94% |
06-21 | Evercore ISI Boosts Price Target on Insmed to $75 From $42, Maintains Outperform Rating | MT |
06-20 | JPMorgan Raises Insmed's Price Target to $72 From $55, Maintains Overweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+124.94% | 11.03B | |
+16.45% | 123B | |
+21.96% | 115B | |
+23.73% | 25.85B | |
-20.05% | 20.9B | |
-16.28% | 16.77B | |
-16.52% | 16.52B | |
-44.35% | 15.56B | |
+63.91% | 15.49B | |
+2.52% | 13.45B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- Transcript : Insmed Incorporated Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 10